Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty

Clinical Hemorheology and Microcirculation

Volumn 24, Issue 1, 2001, Pages 33-41

  Kesmarky G ^a,b   Toth K ^a   Vajda, G ^b   Habon, L ^b   Halmosi, R ^a   Roth E ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; FIBRINOGEN; GLUTATHIONE; LIPID; OXYGEN RADICAL; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; LEUKOCYTE; MALE; OXIDATIVE STRESS; PLASMA VISCOSITY; THROMBOCYTE AGGREGATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FREE RADICALS; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; OXYGEN; PLATELET AGGREGATION; RHEOLOGY;

EID: 0035066318     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. R.R. Azar, R.G. McKay, F.J. Kiernan, B. Seecharran, Y.J. Feng, D.B. Fram, A.H.B. Wu and D.D. Waters, Coronary angioplasty induces a systemic inflammatory response, Am. J. Cardiol. 80 (1997), 1476-1478.
2. O.K. Baskurt, E. Levi, S. Caglayan, N. Dikmenoglu, O. Ucer, R. Guner and S. Yorukan, The role of hemorheologic factors in the coronary circulation, Clin. Hemorheol. 11 (1991), 121-127.
3. R.F. Beers and I.W. Sizer, Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase, J. Biol. Chem. 195 (1952), 133.
4. A.B. Bridges, N.A. Scott, T.H. Pringle, G.P. McNeill and J.J.F. Belch, Relationship between the extent of coronary artery disease and indicators of free radical activity, Clin. Cardiol. 15 (1992), 169-174.
5. C. Carter, D. McGee, D. Reed, K. Yano and G. Stemmermann, Hematocrit and the risk of coronary heart disease: The Honolulu Heart Program, Am. Heart J. 105 (1983), 674-679.
6. S. Chien, Hemorheology in clinical medicine, Clin. Hemorheol. 2 (1982), 137-142.
7. L. Dintenfass, Blood rheology in pathogenesis of the coronary heart diseases, Am. Heart J. 77 (1969), 139-147.
8. E. Ernst, Plasma fibrinogen - an independent cardiovascular risk factor, J. Int. Med. 227 (1990), 365-372.
9. C. Guarnieri, G. Melandori, I. Caldarera, M. Scheda, A. Ligabue, S. Guizzardi and A. Branzi, Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction, Cell. Biochem. Funct. 8 (1990), 157.
10. W.B. Kannel, R.B. D' Agostino and A.J. Belanger, Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study, Am. Heart J. 113 (1987), 1006-1010.
11. G. Késmárky, K. Tóth, L. Habon, G. Vajda and I. Juricskay, Hemorheological parameters in coronary artery disease, Clin. Hemorheol. Microcirc. 18 (1998), 245-251.
12. W. Koenig, E. Ernst and A. Matrai, Blood rheology associated with cardiovascular risk factors and chronic cardiovascular diseases: results of an epidemiologic cross-sectional study, Angiology 39 (1988), 986-995.
13. G.D.O. Lowe, M.M. Drummond, A.R. Lorimer, I. Hutton, C.D. Hutton, C.R.M. Prentice and J.C. Barbenel, Relation between extent of coronary heart disease and blood viscosity, Br. Med. J. 280 (1980), 673-674.
14. G.D.O. Lowe, W.C.S. Smith, H.D. Tunstall-Pedoe, I.K. Crombie, S.E. Lennie, J. Anderson and J.C. Barbenel, Cardiovascular risk and haemorheology - Results from the Scottish Heart Health Study and the MONICA Project, Glasgow, Clin. Hemorheol. 8 (1988), 517-524.
15. A. Matrai, R.B. Whittington and E. Ernst, A simple method of estimating whole blood viscosity at standardized hematocrit, Clin. Hemorheol. 7 (1987), 261-265.
16. H.P. Misra and I. Fridovich, The role of superoxide anion in the autooxidation of epinephrine, a simple assay for superoxide dismutase, J. Biol. Chem. 247 (1972), 3170.
17. G. Montalescot, A. Ankri, E. Vicaut, G. Drobinski, Y. Grosgogeat and D. Thomas, Fibrinogen after coronary angioplasty as a risk factor for restenosis, Circulation 92 (1995), 31-38.
18. G. Montalescot, J.P. Collet, R. Choussat and D. Thomas, Fibrinogen as a risk factor for coronary heart disease, Eur. Heart J. 19(Suppl. H) (1998), H11-H17.
19. F.J. Neumann, H. Tillmanns, P. Roebruck, R. Zimmermann, H.M. Maupt and W. Kubler, Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity, Br. Heart J. 62 (1989), 421-428.
20. F.J. Neumann, H.A. Katus, E. Hoberg, P. Roebruck, M. Braun, H.M. Haupt, H. Tillmanns and W. Kubler, Increased plasma viscosity and erythrocyte aggregation - indicators of an unfavourable clinical outcome in patients with unstable angina pectoris, Br. Heart J. 66 (1991), 425-430.
21. G.S. Oostenbrag, R.P. Mensink, F.W. Bär and G. Hornstra, Lipid peroxidation-associated oxidative stress during percutaneous transluminal coronary angioplasty in humans, Free Radic. Biol. Med. 22 (1997), 129-136.
22. Z.A. Placer, L.L. Cushman and B.C. Johnson, Estimation of product of lipid peroxidation (malondialdehyde) in biochemical systems, Anal. Biochem. 16 (1966), 359.
23. S. Pucheu, C. Coudray, G. Vanzetto, A. Favier, J. Machecourt and J. De Leiris, Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis: utility of assaying plasma malondialdehyde, Free Radic. Biol. Med. 19 (1995), 873-881.
24. C. Rainer, D.T. Kawanishi, P.A.N. Chandraratna, R.M. Bauersachs, C.L. Reid, S.H. Rahimtoola and H.J. Meiselman, Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease, Circulation 76 (1987), 15-20.
25. J. Sedlak and R.H. Lindsay, Estimation of total protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent, Anal. Biochem. 25 (1968), 192.
26. C.V. Serrano, J.A.F. Ramires, M. Venturinelli, S. Arie, E. D'Amico, J.L. Zweier, F. Pileggi and P.L. Da Luz, Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty, J. Am. Coll. Cardiol. 29 (1997), 1276-1283.
27. P.M. Sweetnam, H.F. Thomas, J.W.G. Yarnell, A.D. Beswick, I.A. Baker and P.C. Elwood, Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease: The Caerphilly and Speedwell Studies, Eur. Heart J. 17 (1996), 1814-1820.
28. K. Tóth, B. Mezey, I. Juricskay and T. Javor, Hemorheological changes during the hospital phase of acute myocardial infarction: sex differences?, Med. Sci. Res. 17 (1989), 841-844.
29. K. Tóth, B. Mezey, I. Juricskay, T. Simor and T. Javor, Hemorheological changes during the first six months after acute myocardial infarction [Hungarian], Orv. Hetil. 131 (1990), 727-730.
30. K. Tóth, L. Bogar, I. Juricskay, M. Keltai, S. Yusuf, L.J. Haywood and H.J. Meiselman, The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction (CORE Trial substudy), Clin. Hemorheol. Microcirc. 17 (1997), 117-125.
31. K. Tóth, G. Késmárky, L. Habon, G. Vajda, T. Habon and I. Juricskay, Hemorheology and hemodynamics: A complex approach to the coronary circulation and development of myocardial ischemia, in: Cardiovascular Flow Modelling and Measurement with Application to Clinical Medicine, S.G. Sajjadi, G.B. Nash and M.W. Rampling, eds, Oxford University Press, Oxford, 1999, pp. 163-174.
32. J.W. Yarnell, I.A. Baker, P.M. Sweetnam, D. Bainton, J.R. O-Brien, P.J. Whitehead and P.C. Elwood, Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies, Circulation 83 (1991), 836-844.
33. I.S. Young, J.A. Purvis, J.H. Lightbody, A.J. Adgey and E.R. Trimble, Lipid peroxidation and antioxidant status following thrombolytic therapy for acute myocardial infarction, Eur. Heart J. 14 (1993), 1027-1033.